Peter Marks reports recommendations vaccine and Peter Marks

FDA And CDC Recommend Pausing Johnson & Johnson Covid Vaccine During Investigation Of Reports Of “Extremely Rare” Blood Clots

Reading now: 693
deadline.com

The Food and Drug Administration and the Centers for Disease Control are recommending a pause on the Johnson & Johnson Covid vaccine after reports of what the agencies characterize as an “extremely rare” blood clot.The FDA and the CDC will review “six reported U.S.

cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine,” out of 6.8 million doses administered, according to a statement from Peter Marks, the FDA’s director, Center for Biologics Evaluation and Research, and Anne Schuchat, principal deputy director of the CDC.“FDA will review that analysis as it also investigates these cases.

Read more on deadline.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA